Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03161067 · ClinicalTrials.gov registry record · NA
Investigation on the Bidirectional Cortical Neuroprosthetic System
A NA study of Tetraplegia and Quadriplegia, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03161067: Recruiting NA study of Tetraplegia and Quadriplegia, sponsored by Johns Hopkins University.
NCT03161067 is a NA study of Tetraplegia and Quadriplegia that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 5 participants, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03161067, a NA study of Tetraplegia and Quadriplegia, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The Bidirectional Cortical Neuroprosthetic System (BiCNS) consists of NeuroPort Microelectrode Array Systems and NeuroPort Electrodes (Sputtered Iridium Oxide Film), Patient Pedestals, the NeuroPort BioPotential Signal Processing System, and the CereStim C96 Programmable Stimulator. The goals of this early feasibility study consist of safety and efficacy evaluations of this device.
Primary Outcome
This outcome will be considered successful if the device is not explanted during the 52-week period. Explantation of the device prior to the 52-week study period implies that the device is putting the subject at risk (e.g. through a serious infection at implantation site) and therefore must be removed.
Conditions Studied
Interventions
- DEVICE BiCNS
Study Locations (1)
Maryland
- Department of Neurology - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT03161067 shows while recruiting
NCT03161067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Tetraplegia appearing as the primary indexed condition, and to 1 intervention - of which BiCNS is the first listed.
NCT03161067 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03161067 about?
NCT03161067 is a clinical study titled "Investigation on the Bidirectional Cortical Neuroprosthetic System". The Bidirectional Cortical Neuroprosthetic System (BiCNS) consists of NeuroPort Microelectrode Array Systems and NeuroPort Electrodes (Sputtered Iridium Oxide Film), Patient Pedestals, the NeuroPort BioPotential Signal Processing System, and the CereStim C96 Programmable Stimulator. The goals of thi...
What is the current status of trial NCT03161067?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2017-08-01. Estimated completion is 2027-09-30.
What conditions does trial NCT03161067 study?
This clinical trial studies the following conditions: Tetraplegia, Quadriplegia.
What interventions are being tested in trial NCT03161067?
The interventions under investigation include: BiCNS (DEVICE).
Who is sponsoring clinical trial NCT03161067?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03161067 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetraplegia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03161067's enrollment target sits among peer trials
5 20th of 23 higher than 4 of 23 other Tetraplegia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tetraplegia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Evaluation of an Advanced Lower Extremity Neuroprostheses
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
-
Investigation on the Cortical Communication (CortiCom) System
RECRUITING · NA
-
A Neuroprosthesis for Seated Posture and Balance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI